HAI Solutions Secures FDA De Novo Clearance for UVC-Based QIKCAP IV Connector Disinfection System
HAI Solutions, a company focused on ultraviolet (UVC) microbial reduction technologies for healthcare settings, announced that the US Food and Drug Administration (FDA) has granted De Novo classification to its QIKCAP System.
HAI Solutions | 02/01/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy